SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-027527
Filing Date
2023-08-04
Accepted
2023-08-04 16:02:43
Documents
64
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-20230630.htm   iXBRL 10-Q 1426995
2 EX-31.1 vir-20230630xex311.htm EX-31.1 10790
3 EX-31.2 vir-20230630xex312.htm EX-31.2 10752
4 EX-32.1 vir-20230630xex321.htm EX-32.1 8122
  Complete submission text file 0001628280-23-027527.txt   5995110

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20230630.xsd EX-101.SCH 44794
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vir-20230630_cal.xml EX-101.CAL 74511
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20230630_def.xml EX-101.DEF 181699
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20230630_lab.xml EX-101.LAB 583075
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20230630_pre.xml EX-101.PRE 361745
58 EXTRACTED XBRL INSTANCE DOCUMENT vir-20230630_htm.xml XML 637152
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 231143935
SIC: 2836 Biological Products, (No Diagnostic Substances)